Julius Chapiro

Professor with expertise in Radiology, Digestive Diseases (Hepatology), and Biomedical Engineering, Dr. Julius Chapiro is an esteemed Associate Professor at Yale University. His pioneering research is centered on the development of quantitative imaging biomarkers for liver cancer, a field in which he has made significant strides. Dr. Chapiro's work is instrumental in advancing the understanding of the tumor microenvironment and the role of embolic agents, the immune system, and artificial intelligence in cancer treatment. In addition to his research, Dr. Chapiro is deeply committed to education and mentorship. He actively mentors students and peers, fostering the next generation of leaders in biomedical engineering and radiology. His dedication to academic excellence is further demonstrated through his role on the Editorial Board of the Journal of Hepatology and Radiology (RSNA), where he contributes to shaping the future of these fields. Dr. Chapiro also plays a vital role in the Society of Interventional Oncology, serving on its Grant Committee. His leadership extends to the "Rising Star" Student Exchange Program, which he co-initiated to provide students with unique learning opportunities. As the Director of the Center for Minimally Invasive Therapies, he oversees innovative research and clinical practices aimed at improving patient outcomes through less invasive treatment options. His contributions to the field of biomedical engineering and radiology are widely recognized, and his work continues to influence both academic and clinical practices. Dr. Chapiro's commitment to integrating cutting-edge technology with medical research makes him a leading figure in the quest to enhance diagnostic and therapeutic strategies for liver cancer.